I would like to congratulate the above-mentioned authors on their timely review 1 and P Ljungman on the accompanying editorial. As a pediatrician working in the field of vaccinology, I would like to raise a few comments.
In the editorial in Table 1 it is stated that vaccination against infections caused by Haemophilus influenzae (type b) should be 'season dependent'. While this is certainly true for vaccination against influenza -a viral illness with a clear seasonal pattern -the lack of a recognizable seasonal pattern for invasive Hib diseases does not appear to justify 'season dependent' immunisation against Hib.
In the review, the authors state that 'mumps vaccine . . . should generally be administered only to children'. The reason for this statement remains unclear. It is well known that complications caused by mumps virus such as orchitis and consequent infertility as well as meningoencephalitis are more common in adolescents and adults than in children. Therefore, immunization of seronegative adolescents (and adults) is recommended by the American Academy of Pediatrics. 2 With respect to tetanus immunization after BMT or PBSCT, the authors recommend three doses of DT vaccine (or DTP in children Ͻ7 years of age) in 1-month intervals as a primary series. However, the current recommendations for primary immunization against diphtheria, tetanus, and pertussis in most countries including the USA comprise three doses of Td (with reduced amounts of diphtheria toxoid) at a 1-2 month interval between the first and second dose and a 6-12 month interval between the second and third dose in children Ͼ7 years of age and four doses of DTaP (preferably with an acellular pertussis component with lower rates of side-effects compared to whole cell pertussis vaccines) with 1-2 month intervals between the first three doses and a 6-12 month interval between the third and fourth dose. 3 Finally, with respect to the use of varicella vaccine in household members of patients after BMT or PBSCT, the authors correctly mention the possibility that varicella zoster vaccine virus may be subject of transmission and give recommendations such as avoiding vaccination of members of the respective households or application of acyclovir prophylaxis. They do not, however, mention what I believe would be the most elegant strategy: to screen all household members of patients for the presence of IgG antibodies against VZV as soon as a patient is considered for transplantation, but before he reaches the state of immunosuppression. All IgG-negative persons could then be immunized immediately under practically safe conditions.
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